Year-over-year earnings per share growth for the last twelve months: sonomapharma.com (SNOA)

Sonoma Pharmaceuticals, Inc. - graphic logo of issuer SNOA

Stable demand for antiseptics ensures that Sonoma Pharmaceuticals (SNOA) maintains profit resilience during crises. The quarterly earnings per share growth rate clearly demonstrates this trend, where the current metric is 96.20. Risks are minimized through the supply of wound healing products to global pharmacy chains. Growth is driven by the introduction of innovative Microcyn product lines into new markets.

Sonoma Pharmaceuticals, Inc. (SNOA) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for Sonoma Pharmaceuticals, Inc. (SNOA)

- company stock exchange capitalization indicators:
Comprehensive company analysis:Sonoma Pharmaceuticals
Manufactured product of sonomapharma.com

For the technological leader in regenerative nano-formulas and antiseptics, Sonoma Pharmaceuticals (SNOA), quarterly EPS growth serves as an indicator of the effectiveness of monetizing innovations in dermatitis treatment. By analyzing the quarterly earnings per share trend, investors assess the impact of fiscal changes and subsidies on net income, determining whether the company's market successes offset rising operating expenses and the tax burden.

Main competitors

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel)|Year-over-year earnings per share growth for the last twelve months Oruka Pharma (ORKA)|Year-over-year net earnings per share change for the last twelve months Sanara MedTech|Quarterly EPS earnings growth DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Earnings per share growth in annualized terms for the last twelve months|DERM: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months FBRX (Forte Biosciences)|Empro Group (EMPG) - Year-over-year earnings per share growth for the last twelve months|Net earnings per share growth for the trailing year Sol-Gel Technologies Ltd. SLGL|Year-over-year net earnings per share growth for the last 12 months AXIL|Year-over-year net earnings per share growth for the last 12 months Medicus Pharma Ltd. (MDCX)|Quarterly EPS earnings growth VRCA|Year-over-year earnings per share growth rate for the last twelve months HOTH|Year-over-year earnings per share growth for the last twelve months biofrontera-us.com BFRI|Year-over-year earnings per one share growth for the last 12 months VYNE|Quoin Pharmaceuticals Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Azitra Corporation AZTR|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|Elevai Labs Inc. (ELAB) - Quarterly EPS earnings growth|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth